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Background: Hypertrophic cardiomyopathy (HCM) occurs in 1/500 adults. It is the most common cause of sudden death in the young. In 60% 
of adolescents and adults it is an autosomal dominant trait caused by mutations in sarcomere genes, but 40% of cases remain unexplained. Next-
generation sequencing (NGS) potentially increases the yield of variant detection, facilitates the study of large cohorts and can be used to discover 
novel causal/modifier genes. Its impact on genetic testing strategies in HCM is to be determined. Our aim was to establish methodology for the 
clinical use of NGS in HCM and to characterize HCM genetic determinants.
Methods: DNA was isolated from blood lymphocytes. A genomic DNA library was prepared, covering coding, intronic and regulatory regions of 
20 genes associated with HCM and dilated cardiomyopathy and 20 genes implicated in other cardiomyopathies, channelopathies and arrhythmia 
syndromes. DNA was sequenced by paired-end multiplexing on the Illumina Genome Analyzer IIx. Indels and single-nucleotide polymorphisms were 
called using samtools. We filtered for candidate causal variants (vts), selecting for a frequency <0.5% in the 1000-genomes project and a predicted 
functional role (non-synonymous, loss-of-function or splice change).
Results: 152 HCM probands (age 46(15) years, 75% males). Average read depth in the target region 112x. Variant calling generated 15250 exonic 
and splice-site calls (1046 distinct vts). After filtering, 337 vts were selected. In total, 137 probands (90%) carried at least one candidate variant 
(111 (73%) carried multiple). Excluding titin (157 vts), 83 sarcomeric and 28 Z-disc and calcium-handling vts were identified in 96 probands (63%): 
44 published, 27 novel nonsense, indels or splice-site vts and 14 novel missense vts predicted to be pathogenic. Additionally, 71 vts (7 published) 
were present in genes implicated in other cardiomyopathies, channelopathies and arrhythmia syndromes.
Conclusions: Our protocol allows high coverage of targeted genes and reliable detection of a large number of published and novel variants. The 
high proportion of probands with multiple variants challenges the current understanding of HCM as a monogenetic disease.
